|

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

RECRUITINGSponsored by Emory University
Actively Recruiting
SponsorEmory University
Started2026-06
Est. completion2031-05
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations17 sites

Summary

The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB

Exclusion Criteria:

* Patients under the age of 18; PCI procedures without the utilization of DCB; PCI procedures for non de novo lesions

Conditions2

Coronary Artery DiseaseHeart Disease

Locations17 sites

Banner University Medical Center
Holy Cross Health Fort Lauderdale
Fort Lauderdale, Florida, 33308
Josh Purow, MD
Emory University Hospital Midtown
Emory University Hospital
Emory Saint Joseph's Hospital

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.